Capex / expansionMajor developmentFiled on BSE ·

Fineotex Chemical Q1 FY27 consolidated total income up 164%, PAT up 93% YoY

Fineotex Chemical · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read
₹387 CrCapex / expansion

Key highlights

  • Q1 FY27 consolidated total income ₹386.72 crore, up 164.48% YoY from ₹146.22 crore; EBITDA up 134.69% to ₹59.14 crore
  • Q1 FY27 consolidated PAT ₹48.21 crore, up 92.67% YoY from ₹25.03 crore; results are unaudited
  • Commissioned major capacity expansion at Texas facility, taking total manufacturing capacity to approximately 1,48,000 MTPA

Why it's rated major development: the year-on-year change is 93% (50% or more)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Fineotex Chemical

Other capex / expansion filings this fortnight

All capex / expansion filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.